Regulation of medical devices and their clinical trials studies in the USA: An update

被引:0
|
作者
Manita [1 ]
Deep A. [1 ]
Vikram [1 ]
Rana A.C. [1 ]
Yadav M. [1 ]
Marwaha R.K. [2 ]
机构
[1] Department of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani, 127021, Haryana
[2] Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana
关键词
Certification; Clinical trials; Diagnosis; Medical devices; Regulation; United States Pharmaco-poeia (USP);
D O I
10.2174/2405520412666190828202733
中图分类号
学科分类号
摘要
Background: Need for Medical devices is very important in the healthcare sector and related processes for global regulation. Medical devices are the apparatus or instruments which are specifically used for diagnostics and therapeutic applications. In the USA, a regulatory body known as FDA (Food and Drug Administration) has its unit called CDRH which looks the manufacture, packaging and use of medical devices in the USA. Objective: In USA, Medical devices are classified into 3 classes: class I which look for the medical devices used for the general control as dental floss and bandages, etc., class II which regulate the medical devices used for the general control as well as special control as pow-ered wheelchairs and pregnancy kits. Class III medical devices look the general control. PMA (Premarket Approval) and Premarket Notification application has been filed to FDA for seeking the market authorization of medical devices. We perform clinical trials for medical device which are quite different from the clinical trials performed for drug analysis. These trials are performed on various age groups such as on paediatrics, adult and old age group commonly called phase 1,2,3,4. Regulatory approval of high-risk medical device is based on clinical studies submitted with pre-market approval. The main objective of this article is to make the researcher aware of the regulation and clinical trials of medical devices in the USA. Conclusion: Every medical device should comply with FDA, QMS and QSR for marketing in the USA. The present article has focused on the regulation of medical devices, clinical trial phases and clinical studies on medical devices. © 2020 Bentham Science Publishers.
引用
收藏
页码:94 / 109
页数:15
相关论文
共 50 条
  • [21] REGULATORY SCIENCE Trust and transparency in clinical trials of medical devices
    Kramer, Daniel B.
    Cutlip, Donald E.
    NATURE REVIEWS CARDIOLOGY, 2015, 12 (09) : 503 - 504
  • [22] Specific barriers to the conduct of randomised clinical trials on medical devices
    Edmund A. M. Neugebauer
    Ana Rath
    Sunya-Lee Antoine
    Michaela Eikermann
    Doerthe Seidel
    Carsten Koenen
    Esther Jacobs
    Dawid Pieper
    Martine Laville
    Séverine Pitel
    Cecilia Martinho
    Snezana Djurisic
    Jacques Demotes-Mainard
    Christine Kubiak
    Vittorio Bertele
    Janus C. Jakobsen
    Silvio Garattini
    Christian Gluud
    Trials, 18
  • [23] Specific barriers to the conduct of randomised clinical trials on medical devices
    Neugebauer, Edmund A. M.
    Rath, Ana
    Antoine, Sunya-Lee
    Eikermann, Michaela
    Seidel, Doerthe
    Koenen, Carsten
    Jacobs, Esther
    Pieper, Dawid
    Laville, Martine
    Pitel, Severine
    Martinho, Cecilia
    Djurisic, Snezana
    Demotes-Mainard, Jacques
    Kubiak, Christine
    Bertele, Vittorio
    Jakobsen, Janus C.
    Garattini, Silvio
    Gluud, Christian
    TRIALS, 2017, 18
  • [24] Prioritizing Women's Inclusion in Clinical Trials of Medical Devices
    Holtzman, Jessica N.
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2024, 184 (08)
  • [25] Melanoma: medical trials update
    Eisen, T
    KEY ADVANCES IN THE CLINICAL MANAGEMENT OF SKIN CANCER, 2004, : 45 - 51
  • [26] Clinical trials update
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (10): : 51 - 52
  • [27] Clinical Trials Update
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2011, 31 (15): : 60 - 63
  • [28] Clinical trials update
    不详
    GENETIC ENGINEERING NEWS, 2003, 23 (07): : 5 - +
  • [29] Clinical trials update
    Loshak, D
    CIRCULATION, 2006, 113 (02) : F8 - F8
  • [30] Clinical Trials Update
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (17): : 54 - +